Skip to main content
SpringerLink
Log in

Leukocyte Adhesion Deficiency III - When Integrins Activation Fails

  • Key Review Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Schmidt S, Moser M, Sperandio M. The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol. 2013;55:49–58.

    Article  CAS  PubMed  Google Scholar 

  2. Hanna S, Etzioni A. Leukocyte adhesion deficiencies. Ann N Y Acad Sci. 2012;1250:50–5.

    Article  CAS  PubMed  Google Scholar 

  3. Etzioni A, Frydman M, Pollack S, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327:1789–92.

    Article  CAS  PubMed  Google Scholar 

  4. Kuijpers TW, Van Lier R, Hamann D, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest. 1997;100:1725–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. McDowall A, Inwald D, Leitinger B, et al. A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. J Clin Invest. 2003;111(1):51–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Alon R, Aker M, Feigelson S, et al. A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood. 2003;101:4437–45.

    Article  CAS  PubMed  Google Scholar 

  7. Harris ES, Shigeoka AO, Li W, Adams RH, Prescott SM, McIntyre TM, et al. A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins. Blood. 2001;97:767–76.

    Article  CAS  PubMed  Google Scholar 

  8. Alon R, Etzioni A. LAD III a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561–6.

    Article  CAS  PubMed  Google Scholar 

  9. van de Vijver E, van den Berg TK, Kuijpers TW, et al. Leukocyte adhesion deficiencies. Hematol Oncol Clin N Am. 2013;27:101–16.

    Article  Google Scholar 

  10. Kuijpers TW, van Bruggen R, Kamerbeek N, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood. 2007;109:3529–37.

    Article  CAS  PubMed  Google Scholar 

  11. Moutsopoulos NM, Konkel J, Samadi M, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17 driven inflammatory bone loss. Sci Transl Med. 2014;6:229ra40v.

    Article  Google Scholar 

  12. Etzioni A. Genetic etiologies of leukocyte adhesion defects. Curr Opin Immunol. 2009;21:481–6.

    Article  CAS  PubMed  Google Scholar 

  13. van de Vijver E, De Cuyper IM, Gerrits AJ, et al. Defects in Glanzmann thrombasthenia and LAD III (LAD-I/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen. Blood. 2012;119:583–6.

    Article  PubMed  Google Scholar 

  14. Kinashi T, Aker M, Sokolovsky-Eisenberg M, et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood. 2004;103:1033–6.

    Article  CAS  PubMed  Google Scholar 

  15. Pasvolsky R, Feigelson SW, Kilic S, et al. LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med. 2007;204(7):1571–82.

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Malinin NL, Zhang L, Choi J, et al. A point mutation in kindlin3 ablates activation of three integrin subfamilies in humans. Nat Med. 2009;15:313–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Etzioni A, Alon R. Cell adhesion and leukocyte adhesion defects. In: Ochs HD, Smith EM, Puck J, editors. Primary immune deficiency disease. A molecular and genetic approach. 3rd ed. Oxford: Oxford University; 2014. p. 723–41.

    Google Scholar 

  18. Gruda R, Brown AC, Grabovsky V, et al. Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III. Blood. 2012;120(19):3915–24.

    Article  CAS  PubMed  Google Scholar 

  19. Crittenden JR, Bergmeier W, Zhang Y, et al. CalDAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nat Med. 2004;10(9):982–6.

    Article  CAS  PubMed  Google Scholar 

  20. Harris ES, Smith TL, Springett GM, et al. Leukocyte adhesion deficiency I-variant syndrome(LAD-Iv, LADIII): molecular characterization of the defect in an index family. Am J Hematol. 2012;87:311–3.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Moser M, Nieswandt B, Ussar S, et al. Kidlin3 is essential for integrin activation and platelet aggregation. Nat Med. 2008;14:325–30.

    Article  CAS  PubMed  Google Scholar 

  22. Fagerholm SC, Lek HS, Morrison VL. Kindlin -3 in the immune system. Am J Clin Exp Immunol. 2014;3:37–42.

    PubMed Central  PubMed  Google Scholar 

  23. Meves A, Stremmel C, Gottschalk K, Fässler R. The Kindlin protein family: new members to the club of focal adhesion proteins. Trends Cell Biol. 2009;19:504–13.

    Article  CAS  PubMed  Google Scholar 

  24. Morrison VL, Macpherson M, Savinko T, et al. The beta2 integrin-kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo. Blood. 2013;122:1428–36.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Lefort CT, Rossaint J, Moser M, et al. Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood. 2012;119:4275–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Cohen SJ, Gurevich I, Feigelson SW, et al. The integrin coactivator Kindlin 3 is not required for lymphocyte diapedesis. Blood. 2013;122:2609–17.

    Article  CAS  PubMed  Google Scholar 

  27. Schmidt S, Nakchbandi I, Ruppert R, et al. Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. J Cell Biol. 2011;192:883–97.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Kilic SS, Etzioni A. The clinical spectrum of leukocyte adhesion deficiency (LAD) III due to defective CalDAG-GEF1. J Clin Immunol. 2009;29(1):117–22.

    Article  CAS  PubMed  Google Scholar 

  29. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency III is caused by mutations in kindling 3 affecting integrin activation. Nat Med. 2009;15:306–12.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Mory A, Feigelson SW, Yarali N, et al. Kindlin3 a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591–2.

    Article  CAS  PubMed  Google Scholar 

  31. Van de Vijver E, Maddalena A, Sanal O, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48:53–61.

    Article  PubMed  Google Scholar 

  32. Kuijpers TW, van de Vijver E, Weterman MAJ, et al. LAD-I/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113:4740–6.

    Article  CAS  PubMed  Google Scholar 

  33. Canault M, Ghalloussi D, Grosdidier C, et al. Human CalDAG-GEFi gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med. 2014;211:1349–62.

    Article  CAS  PubMed  Google Scholar 

  34. Elhasid R, Kilic SS, Ben-Harush M, et al. Prompt recovery of recipient hematopoiesis following two consecutive haploidentical peripheral blood stem cell transplantation in a child with leukocyte adhesion deficiency III (LADIII) syndrome. Bone Marrow Transplant. 2010;45:413–4.

    Article  CAS  PubMed  Google Scholar 

  35. Robert P, Canault M, Farnarier C, et al. A novel leukocyte adhesion deficiency III variant: kindling 3 deficiency results in integrin and nonintegrin related defects in different steps of leukocyte adhesion. J Immunol. 2011;186:5273–83.

    Article  CAS  PubMed  Google Scholar 

  36. Mcdowall A, Svensson L, Stanley P, et al. Two mutations in the Kindlin3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro. Blood. 2010;115:4834–42.

    Article  CAS  PubMed  Google Scholar 

  37. Jurk K, Schulz AS, Kehrel BE, et al. Novel integrin dependent platelet malfunction in siblings with leukocyte adhesion deficiency III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost. 2010;103:1053–64.

    Article  CAS  PubMed  Google Scholar 

  38. Meller J, Malinin NL, Panigrahi S, et al. Novel aspects of Kindlin 3 function in humans basic on a new case of leukocyte adhesion deficiency III. J Thromb Haematol. 2012;10:1397–408.

Download references

Author information

Authors and Affiliations

  1. Ruth Children Hospital, Haifa, Rappaport Medical School, Technion, Haifa, Israel

    Amos Etzioni

  2. Ruth Children Hospital, Rambam Medical Campus, Haifa, 31096, Israel

    Amos Etzioni

Authors
  1. Amos Etzioni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amos Etzioni.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Etzioni, A. Leukocyte Adhesion Deficiency III - When Integrins Activation Fails. J Clin Immunol 34, 900–903 (2014). https://doi.org/10.1007/s10875-014-0094-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-014-0094-4

Keywords

Search

Navigation